ANL · Adlai Nortye Ltd.
$13.22
-0.04 (-0.30%)
At close · Jul 23
Market Cap
$851.34M
Shares
64.40M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$13.22
Open$13.25
Day$12.98–13.50
52W$0.88–17.25
Avg vol 30d209K
Short int3.3M · 5.2% float · 23.1d
Short vol59%
DataSep 2023–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+86%
above
Price vs 50-day avg
+19%
above
RSI (14)
64
neutral
MACD trend
Positive
52-week position
75%
mid-range
Momentum
relative strength
1-month return
+20%
trailing
6-month return
+102%
trailing
YTD return
+831%
this year
Relative strength
+96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $7 — 50d above 200d
Institutional flow
Distributing
2 of 26 funds reported for Jun 30 · net -14.4K sh shares · +1 new
Insider flow
Distributing
Net -$132 over 90 days · 100% sells
Short interest
Rising
5.18% of float · ▲ +0.2% MoM · 23.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
26 holders — near 3-yr high, broad support
Squeeze score
70
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
148%
annualized · 1-yr
Max drawdown
−51%
past year
ATR
9.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+86%
Bullish
Price vs 50-day avg
+19%
Bullish
RSI (14)
64
Neutral
MACD trend
Positive
Bullish
52-week position
75%
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $11 › 200d $7 — 50d above 200d
Institutional flow
Distributing
2 of 26 funds reported for Jun 30 · net -14.4K sh shares · +1 new
Insider flow
Distributing
Net -$132 over 90 days · 100% sells
Short interest
Rising
5.18% of float · ▲ +0.2% MoM · 23.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
26 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $13 · 75%
52-wk high $17
vs 200-day avg +86%
vs 50-day avg +19%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ANL
this stock
Adlai Nortye Ltd.
|
$851.34M | +831.0% | — | — | 5.2% |
|
ONC
BeOne Medicines Ltd.
|
$472.27B | +7.6% | +22179.2% | 961.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$120.07B | +4.4% | +46.2% | 28.1 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.35B | -15.4% | +20.8% | 15.9 | 3.3% |
|
ARGX
Argenx SE
|
$57.84B | +9.9% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ANL | +16.5% | +20.3% | +102.5% | +15.0% | +831.0% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +18.2% | +19.6% | +96.1% | +16.1% | +822.7% |